172 results
·
37ms
·
Sources: EU EUDAMED, US FDA
Filters
FDA Classification
×
Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device
FDA classification
FDA Class 2
·Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device
System, Test, Fibrin/Fibrinogen Degradation Products For Monitoring Of Colorectal Cancer
FDA classification
FDA Class 2
·System, Test, Fibrin/Fibrinogen Degradation Products For Monitoring Of Colorectal Cancer
Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.
FDA classification
FDA Class 2
·Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease.
Container, Empty, For Collection & Processing Of Blood & Blood Components
FDA classification
FDA Class 2
·Container, Empty, For Collection & Processing Of Blood & Blood Components
Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
FDA classification
FDA Class 2
·Temporarily-Placed Urethral Opening System For Symptoms Of Benign Prostatic Hyperplasia
Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia
FDA classification
FDA Class 3
·Daily Wear Soft Contact Lens To Reduce The Progression Of Myopia
Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis
FDA classification
FDA Class 2
·Lasers For Temporary Increase Of Clear Nail In Patients With Onychomycosis
Mobile / Tablet Software Application To Control Settings Of Surgical And Endoscopic Camera
FDA classification
FDA Class 2
·Mobile / Tablet Software Application To Control Settings Of Surgical And Endoscopic Camera
Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
FDA classification
FDA Class 3
·Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19
FDA classification
FDA Not Classified
·Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19
Substance, Blood Grouping Of Non-Human Origin For In Vitro Diagnostic Use
FDA classification
FDA Class 2
·Substance, Blood Grouping Of Non-Human Origin For In Vitro Diagnostic Use
Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
FDA classification
FDA Class 2
·Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna
Device To Detect Antigens Of Biothreat Microbial Agents In Human Clinical Specimens
FDA classification
FDA Class 2
·Device To Detect Antigens Of Biothreat Microbial Agents In Human Clinical Specimens
Combined Acoustic And Electrical External Stimulation Device For The Relief Of Tinnitus
FDA classification
FDA Class 2
·Combined Acoustic And Electrical External Stimulation Device For The Relief Of Tinnitus
Serology Tests Used For Infectious Disease Screening Of Blood And Plasma Donations
FDA classification
FDA Unclassified
·Serology Tests Used For Infectious Disease Screening Of Blood And Plasma Donations
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA classification
FDA Class 3
·Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
FDA classification
FDA Class 3
·Percutaneous Cardiac Ablation Catheter For Treatment Of Atrial Fibrillation With Irreversible Electroporation
System, Intravaginal, For Controlled Release Of Drug Substance, Cder Or Cber Led
FDA classification
FDA Not Classified
·System, Intravaginal, For Controlled Release Of Drug Substance, Cder Or Cber Led
Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users
FDA classification
FDA Class 2
·Test For Detection Of Antibodies Associated With Syphilis Performed By Lay Users